Exact Sciences (EXAS) Asset Writedowns and Impairment (2020 - 2025)

Exact Sciences (EXAS) has 6 years of Asset Writedowns and Impairment data on file, last reported at $406000.0 in Q4 2025.

• Asset Writedowns and Impairment for Q4 2025 came in at $406000.0, down 99.95% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.2 million (down 99.17% YoY), and the FY2025 annual result was $7.2 million, down 99.17% from the prior year.
• Asset Writedowns and Impairment eased to $406000.0 in Q4 2025 per EXAS's latest filing, from $543000.0 in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $838.2 million in Q4 2024 and troughed at $10000.0 in Q4 2021.
• A 5-year average of $65.0 million and a median of $3.9 million in 2022 frame the typical range for Asset Writedowns and Impairment.
• The sharpest annual moves came in 2022 and 2025: Asset Writedowns and Impairment surged 34220.0% in 2022, then tumbled 99.95% in 2025.
• A 5-year view of Asset Writedowns and Impairment shows it stood at $10000.0 in 2021, then surged by 34220.0% to $3.4 million in 2022, then slumped by 83.92% to $552000.0 in 2023, then soared by 151741.3% to $838.2 million in 2024, then plunged by 99.95% to $406000.0 in 2025.
• Business Quant data shows EXAS's Asset Writedowns and Impairment at $406000.0 in Q4 2025, $543000.0 in Q3 2025, and $6.3 million in Q1 2025.